Vermillion Inc Q2 2018 Institutional Investor Sentiment Better Than Expected

September 16, 2018 - By Joseph Norton

Sentiment for Vermillion Inc (NASDAQ:VRML)

Vermillion Inc (NASDAQ:VRML) institutional sentiment increased to 1.57 in Q2 2018. Its up 0.79, from 0.78 in 2018Q1. The ratio improved, as 11 active investment managers increased or opened new equity positions, while 7 sold and trimmed equity positions in Vermillion Inc. The active investment managers in our partner’s database now have: 20.13 million shares, up from 19.93 million shares in 2018Q1. Also, the number of active investment managers holding Vermillion Inc in their top 10 equity positions was flat from 2 to 2 for the same number . Sold All: 4 Reduced: 3 Increased: 6 New Position: 5.

Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance outcomes for women in the United States. The company has market cap of $40.66 million. It is developing novel diagnostic tests for gynecologic disease with focus on ovarian cancer. It currently has negative earnings. The companyÂ’s products include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor.

The stock decreased 1.85% or $0.0102 during the last trading session, reaching $0.5401. About 43,490 shares traded. Vermillion, Inc. (NASDAQ:VRML) has declined 59.06% since September 16, 2017 and is downtrending. It has underperformed by 74.68% the S&P500.

Oracle Investment Management Inc holds 1.85% of its portfolio in Vermillion, Inc. for 9.83 million shares. Birchview Capital Lp owns 2.23 million shares or 1.18% of their US portfolio. Moreover, Morgens Waterfall Vintiadis & Co Inc has 0.55% invested in the company for 1.00 million shares. The Connecticut-based Manatuck Hill Partners Llc has invested 0.12% in the stock. Greenwich Wealth Management Llc, a Connecticut-based fund reported 215,521 shares.

Since January 1, 0001, it had 2 buys, and 0 sales for $4.95 million activity.

More news for Vermillion, Inc. (NASDAQ:VRML) were recently published by: Globenewswire.com, which released: “Vermillion, Inc. Appoints Nancy Cocozza to its Board of Directors” on August 21, 2018. Nasdaq.com‘s article titled: “Vermillion, Inc. Kicks Off Ovarian Cancer Awareness Month by Ringing the NASDAQ Closing Bell” and published on September 06, 2018 is yet another important article.

Vermillion, Inc. (NASDAQ:VRML) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.